Tag: Drug Manufacturing

Omeros Corporation and Lonza Announced Long-term Manufacturing Agreement

Biopharma company Omeros Corporation and biotech group Lonza have announced a long-term manufacturing agreement for the commercial production of Omeros’ lead human monocloncal antibody narsoplimab...

Takeda Openes First API Manufacturing Plant outside Japan

Takeda has officially opened a new manufacturing plant at its site at Grange Castle, in Dublin, Ireland. The company CEO, government ministers and industry officials together with staff and guests ...

Grupo RPH and Telix Signed Manufacturing and Distribution Agreement

Telix Pharmaceuticals Limited, a clinical-stage biopharmaceutical company focused on the development of diagnostic and therapeutic products based on targeted radiopharmaceuticals or “molecularly-targe...

Gamida Cell and Lonza Sign Manufacturing Agreement for Omidubicel

gamida cell
Gamida Cell Ltd., a leading cellular and immune therapeutics company, and Lonza announced that the companies have entered into a strategic manufacturing agreement. The agreement provides for the fu...

Drug Production to be Launched in Moscow Special Economic Zone

drug manufacturing
An agreement clearing the pharmaceutical company R-Opra to manufacture drugs in the Technopolis Moscow special economic zone was concluded at the St. Petersburg international economic forum. Under ...

Tergus to Build Plant and Invest in Expanding Commercial Manufacturing

Tergus Pharma (“Tergus”), an end-to-end service provider for topical pharmaceutical research, drug development, testing and manufacturing, has announced a 100,000-square-foot building for its new head...

GSK Agreed to Sell Manufacturing Site in Cork

drug manufacturing
Thermo Fisher Scientific Inc., the world leader in serving science, announced today that it has entered into a definitive agreement to acquire a drug substance manufacturing site in Cork, Ireland, fro...

IQVIA Reports About the Record Number of U.S. Drugs Launched in 2018

Ongoing changes in the clinical development process led to a record number of drug approvals in 2018, with 59 novel treatments reaching patients in the United States alone. During the next five years,...

Catalent to Invest $27m for Next-Generation ODT Technology

Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, announced that it is to invest mor...

AGC boosts its biopharmaceutical production capacity

AGC, a world-leading manufacturer of glass, chemicals and high-tech materials, has announced a major expansion of AGC Biologics, a CDMO subsidiary of the company. At AGC Biologics’ Seattle (USA) si...

WuXi Biologics entered into partnership with AC Immune

WuXi Biologics and AC Immune SA announced the first steps of an exclusive strategic collaboration that covers biologics discovery, development and manufacturing.

Servier celebrated 15 years of operation in Georgia

French pharmaceutical group 'Servier' celebrated 15 years of operation in Georgia at an event attended by representatives of the Ministry of Health, industry specialists and company partners. The o...

Novacap consolidates its CDMO subsidiaries to form SEQENS

Novacap, a global player in the pharmaceutical synthesis and specialty ingredients announced that it will combine its contract development and manufacturing organization subsidiaries.

Roquette and Thermo Fisher entered into distribution agreement

Roquette, a global leader in innovative plant-based pharmaceutical ingredients, and Thermo Fisher Scientific, are announcing a distribution agreement for the Roquette portfolio of pharma ingredients.

Rentschler Biopharma buys US manufacturing facility from Shire

Rentschler Biopharma, a leading contract development and manufacturing organization for biopharmaceuticals, has signed an agreement to purchase a manufacturing facility from an affiliate Shire.

Trimb Healthcare acquires BioClin BV

Trimb Healthcare (Sweden) has completed the acquisition of BioClin BV, a leading intimate healthcare company based in Delft (Netherlands).